tm logo
XENOVIEW
Live/Registered
REGISTERED

on 17 Sep 2024

Last Applicant/ Owned by

P.O. Box 14805

Research Triangle Park

NC

277094805

Serial Number

90135724 filed on 25th Aug 2020

Registration Number

7507918 registered on 17th Sep 2024

in the Principal Register

Correspondent Address

Anthony P. DeRosa

Anthony P. DeRosa MYERS BIGEL, P.A.

RALEIGH, NC 27612

United States

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

XENOVIEW

Hyperpolarized gas production and delivery system for medical imaging, namely, a system for producing hyperpolarized Xenon-129 gas used to obtain magnetic resonance imaging (MRI) data of a patient's lungs comprised of a radiological apparatus for diagnostic and medical purposes in the nature of a Xenon-129 hyperpolarizer, polarimetry measurement stations in the nature of polarimeters, and dose del Read More

Classification Information


Class [010]
Medical Instrument Products


Hyperpolarized gas production and delivery system for medical imaging, namely, a system for producing hyperpolarized Xenon-129 gas used to obtain magnetic resonance imaging (MRI) data of a patient's lungs comprised of a radiological apparatus for diagnostic and medical purposes in the nature of a Xenon-129 hyperpolarizer, polarimetry measurement stations in the nature of polarimeters, and dose delivery bags that facilitate the delivery of doses of inhalable hyperpolarized Xenon-129 gas


First Use Date in General

28th Dec 2022

First Use Date in Commerce

25th Jan 2023

Class [009]
Computer & Software Products & Electrical & Scientific Products


Downloadable computer software for recording, processing, transmitting, displaying, and/or analyzing data and images for use in connection with hyperpolarized gas production and delivery systems for medical imaging, namely, systems for providing hyperpolarized Xenon-129 gas used to obtain magnetic resonance imaging (MRI) data of a patient's lungs


First Use Date in General

28th Dec 2022

First Use Date in Commerce

25th Jan 2023

Class [005]
Pharmaceutical Products


Inhalable contrast agents for in-vivo imaging, in particular, inhalable hyperpolarized Xenon-129 gas delivered to a patient to obtain ventilation and gas exchange image and oscillation data of the patient's lungs; Contrast media for use with imaging medical equipment; Imaging agents for magnetic resonance imaging (MRI)


First Use Date in General

28th Dec 2022

First Use Date in Commerce

25th Jan 2023

Mark Details


Serial Number

No 90135724

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 9930-31

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
17th Sep 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
17th Sep 2024REGISTERED-PRINCIPAL REGISTER
14th Aug 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
14th Aug 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21st Jun 2024ASSIGNED TO LIE
21st Jun 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
21st Jun 2024TEAS/EMAIL CORRESPONDENCE ENTERED
16th Apr 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
06th Feb 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
06th Feb 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED